VICTORY CAPITAL MANAGEMENT INC – Vertex Pharmaceuticals Incorporated Transaction History
VICTORY CAPITAL MANAGEMENT INC portfolio value:
$151.58M
portfolio value
VICTORY CAPITAL MANAGEMENT INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.71% | -25.86K shares | -3.23M | $289.54 | 523.52K |
| Q2 2022 | share | Increase | +5.34% | 27.85K shares | 16.53M | $281.79 | 549.39K |
| Q1 2022 | share | Increase | +205.90% | 351.04K shares | 100.84M | $260.97 | 521.53K |
| Q4 2021 | share | Increase | +2.85% | 4.71K shares | 7.37M | $222.45 | 170.49K |
| Q3 2021 | share | Increase | +3.97% | 6.32K shares | -2.08M | $181.39 | 165.77K |
| Q2 2021 | share | Decrease | -72.19% | -413.82K shares | -91.04M | $201.63 | 159.45K |
| Q1 2021 | share | Decrease | -12.77% | -83.92K shares | -32.13M | $214.89 | 573.27K |
| Q4 2020 | share | Increase | +18.90% | 104.47K shares | 4.91M | $236.34 | 657.2K |
| Q3 2020 | share | Decrease | -5.50% | -32.14K shares | -19.38M | $272.12 | 552.72K |
| Q2 2020 | share | Increase | +11.48% | 60.25K shares | 44.96M | $290.31 | 584.87K |
| Q1 2020 | share | Increase | +50.91% | 176.97K shares | 48.71M | $237.95 | 524.62K |
| Q4 2019 | share | Increase | +134.49% | 199.39K shares | 51M | $218.95 | 347.65K |
| Q3 2019 | share | Increase | +676.45% | 129.16K shares | 21.61M | $169.42 | 148.25K |
| Q2 2019 | share | Increase | +0.35% | 67 shares | 1K | $183.38 | 19.09K |
| Q1 2019 | share | Increase | +404.83% | 15.25K shares | 2.87M | $183.95 | 19.02K |
| Q4 2018 | share | Decrease | -0.66% | -25 shares | -106K | $165.71 | 3.76K |
| Q3 2018 | share | Decrease | -1.20% | -46 shares | 78K | $192.74 | 3.79K |
| Q2 2018 | share | Decrease | -2.04% | -80 shares | 14K | $169.96 | 3.84K |
| Q1 2018 | share | Decrease | -1.88% | -75 shares | 40K | $162.98 | 3.92K |
| Q4 2017 | share | Decrease | -3.99% | -166 shares | -34K | $149.86 | 3.99K |
| Q3 2017 | share | Decrease | -3.03% | -130 shares | 80K | $152.04 | 4.16K |
| Q2 2017 | share | Decrease | -5.07% | -229 shares | 59K | $128.87 | 4.29K |
| Q1 2017 | share | Decrease | -3.09% | -144 shares | 150K | $109.35 | 4.52K |
| Q4 2016 | share | Decrease | -1.42% | -67 shares | -69K | $73.67 | 4.66K |
| Q3 2016 | share | Increase | +49.86% | 1.57K shares | 141K | $87.21 | 4.73K |
| Q2 2016 | share | Decrease | -2.11% | -68 shares | 16K | $86.02 | 3.15K |
| Q1 2016 | share | Decrease | -2.57% | -85 shares | -160K | $79.49 | 3.22K |